The most trusted news from Guinea-Bissau
Provided by AGP
MENAFN
(MENAFN) Guinea-Bissau has terminated a contentious hepatitis B vaccine trial bankrolled by the Trump administration following a sharp ethical rebuke from the World Health Organization (WHO), which warned the study risked causing irreversible harm...
MENAFN
(MENAFN) Guinea-Bissau has terminated a controversial hepatitis B vaccine study financed by the administration of US President Donald Trump after the World Health Organization raised ethical concerns about the project’s design.
MENAFN
(MENAFN) Guinea-Bissau’s military authorities have announced new elections set for December 6, 2026, through a presidential decree issued on Wednesday.
EIN Presswire
On-the-ground investigation raised alarms about safeguards for children, conflicts of interest, and grant oversight.
MENAFN
(MENAFN) Guinea-Bissau's military-led government revealed Wednesday a firm electoral schedule—setting Dec. 6 as the date for presidential and parliamentary polls—the regime's first concrete timeline since seizing control in a November 2025...
EIN Presswire
Following WHO’s statement of concern, Stand Up For Science urges immediate action to halt unethical research practices.
The daily local news briefing you can trust. Every day. Subscribe now.
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
is already signed up. Check your inbox for updates.